Hemostasis and Thrombosis in Obstetrics and Gynecology

A hemostatic change in women through their reproductive lifetime is emerging as an issue of global importance. No wonder, as obstetric hemorrhage remains a major cause of maternal mortality in both developed and developing countries. Thrombophilias and pulmonary embolisms are a threat to maternal and fetal well-being.

Hemostasis and Thrombosis in Obstetrics & Gynecology provides a framework for assessing and managing hemostatic disorders in women. Written by an international team, it provides globally applicable guidelines for obstetric hematology. The practical approach to clinical management includes:

• Hematologic changes in pregnancy
• Red cell disorders
• Platelet disorders
• Inherited and acquired thrombophilia
• Inherited bleeding disorders
• Postpartum hemorrhage

Blood and bleeding disorders in women can be managed by obstetrician-gynecologists or hematologists, separately or together. Hemostasis and Thrombosis in Obstetrics & Gynecology provides specialists from both disciplines with the information necessary to manage their patients effectively.

Michael Paidas, MD, Yale School of Medicine, New Haven, CT, USA  

Nazli Hossain, MBBS, FCPS, Dow University of Health Sciences, Karachi, Pakistan

Tahir Shamsi, MBBS, FRCP, National Institute of Blood Disorders, Karachi, Pakistan

Marc Rodger, MD, Ottawa Hospital Research Institute, Ottawa, Canada

Jens Langhoff-Roos, MD, Rigshospitalet, University of Copenhagen, Denmark.

Charles Lockwood, MD, Yale School of Medicine, New Haven, CT, USA